Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Beadle, Beth M. (1)
- Breast Neoplasms (1)
- Chambers, Mark S. (1)
- Glioblastoma (1)
- Head and Neck Neoplasms (1)
-
- Hofstede, Theresa (1)
- Krishnamurthy, Savitri (1)
- Kuerer, Henry M. (Henry Mark) (1)
- Mastectomy, Segmental (1)
- NF-kappa B (1)
- Osteoradionecrosis (1)
- Paget's Disease, Mammary (1)
- Proton Therapy (1)
- Radiotherapy (1)
- Radiotherapy -- adverse effects (1)
- Smoking Cessation. (1)
- Stauder, Michael (1)
- Strom, Eric A, (1)
- Sulman, Erik (1)
- Transcription Factors (1)
- Xerostomia (1)
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Oncolog, Volume 58, Number 11-12, November - December 2013, Amelia Scholtz, Bryan Tutt, Luanne Jorewicz, K Stuyck
Oncolog, Volume 58, Number 11-12, November - December 2013, Amelia Scholtz, Bryan Tutt, Luanne Jorewicz, K Stuyck
OncoLog MD Anderson's Report to Physicians (All issues)
- Paget Disease of the Breast: A Rare, Often Misdiagnosed Malignancy: A small, scaling rash around the nipple may not be just another case of eczema or dermatitis. Paget disease of the breast, a rare malignancy, is often mistaken for a benign dermatological condition. But Paget disease typically indicates underlying ductal carcinoma in situ or invasive breast cancer
- New Partial-Breast Radiation Therapy Regimen Uses Protons: Whole-or partial-breast radiation therapy can reduce a patient's chance of brest cancer recurrence after lumpectomy, but this benefit must be weighed against the risk of damage to healthy tissue
- Managing Dental Complications in Patients with Head …
Oncolog, Volume 58, Number 03, March 2013, Sarah Bronson, Zach Bohannan, Bryan Tutt
Oncolog, Volume 58, Number 03, March 2013, Sarah Bronson, Zach Bohannan, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Advances in Pulmonary Medicine Facilitate Cancer Diagnosis, Treatment: The lungs present unique challenges in cancer diagnosis and treatment-navigating a maze of bronchi to find and sample tissue that will lead to an accurate diagnosis of lung cancer, for example, or deciding whether to proceed with treatment for cancer in the presence of concomitant lung disease
- New Drugs Increase Treatment Options for Patients with Imatinib-Resistant Chronic Myeloid Leukemia: In the past year, several new targeted drugs have been approved as second-line treatments for imatinib-resistant chronic myeloid leukemia (CML). These drugs include the second-generation tyrosine kinase inhibitor bosutinib and the third-generation tyrosine …